Table 2.
Sociodemographic and Clinical Characteristics of Participants (n = 88)
| Variables | Number of Participants (%) |
|---|---|
| A: Demographic and clinical presentation | |
| Age | |
| <60 | 23(26.1) |
| ≥60 | 65(73.9) |
| Gender | |
| Male | 78(88.6) |
| Female | 10(11.4) |
| Smoking | |
| Yes | 73(83.0) |
| No | 15(17.0) |
| Family history | |
| Yes | 17(19.3) |
| No | 71(80.7) |
| Co-morbidities (HTN, DM, or IHD) | |
| Yes | 65(73.9) |
| No | 23(26.1) |
| Presentation of disease | |
| Haematuria | 63(71.6) |
| Scans (Ultrasound, CT scan, etc) | 16(18.2) |
| LUTS (mainly dysuria) | 5(5.7) |
| Others | 4(4.5) |
| B: Risk stratification, staging and grading | |
| Stage of tumour | |
| pTa | 12(13.6) |
| pT1 | 7(8.0) |
| CIS | 3(3.4) |
| General terminology (Superficial bladder cancer) | 66(75.0) |
| Grade of tumour | |
| Low/PUNLMP | 22(25.0) |
| High | 66(75.0) |
| Risk group | |
| Low | 14(15.9) |
| Intermediate | 11(12.5) |
| High | 63(71.6) |
| Delay of diagnosis | |
| Yes | 44(50.0) |
| No | 44(50.0) |
| Muscles found in the first resection | |
| Yes | 41(46.6) |
| No | 47(53.4) |
| IV-MMC was given at 1st resection | |
| Yes | 9(10.2) |
| No | 79(89.8) |
| C: Compliance, RR, PR, MsR and MR Follow over 3 years | |
| Compliance for all groups | |
| Yes | 20(22.7) |
| No | 68(77.3) |
| Compliance Rate for each risk | |
| Low | 6(42.9) |
| Intermediate | 5(45.5) |
| High | 9(14.3) |
| RR | |
| Yes | 74(84.1) |
| No | 14(15.9) |
| PR | |
| Yes | 34(38.6) |
| No | 46(52.3) |
| Missing | 8(9.1) |
| MetsR | |
| Yes | 24(27.3) |
| No | 56(63.6) |
| Missing | 8(9.1) |
| MR | 16(18.2) |
Abbreviations: LUTS, lower urinary tract symptoms; CT, computed tomography scan; BCG, Bacillus Calmette–Guérin; IV-MMC, intravesical mitomycin; DM, diabetes mellitus; HTN, hypertension; IHD, ischemic heart disease; RR, recurrence rate; PR, progression rate; MetsR, metastatic rate; MR, mortality rate; CIS, carcinoma in situ; PUNLMP, papillary urothelial neoplasm of low malignant potential.